Cardiology

DOACs in Obese Patients Show Similar VTE Recurrence Rates to Non-Obese Patients

August 07, 2020

Article

The study paves the way for prospective multi-institutional randomized control trials to further re-enforce the safe use of direct oral anticoagulants in patients with obesity.

Study Targets Right Alirocumab Dosage for Hypercholesterolemia Patients

August 03, 2020

Article

The most common adverse events were injection-site reactions and headaches.

How VTE Screening Can Be Improved

July 31, 2020

Video

A discussion on how thromboembolism research and care could benefit from progression in diagnostics.

Model Accurately Predicts Benefit of Lipid-Lowering Therapies

July 30, 2020

Article

The model can simulate treatment benefit over time with time-varying low-density lipoprotein cholesterol.

New Data Expands the Risk Pool for Mortality From Elevated Pulmonary Artery Pressure

July 30, 2020

Article

Patients with a mPAP of at least 19 mm Hg and pulmonary artery wedge pressure of 15 mm Hg or less had an adjusted hazard ratio for mortality of 1.71.

VTE May Not Be Significant Driver of Death

July 30, 2020

Article

A new systematic review and meta-analysis challenges the notion that preventing VTE is associated reduced mortality risk.

Inferior Vena Cava Filter Reduces DVT-Cancer Patient Risk of Pulmonary Embolism

July 24, 2020

Article

New findings evidences the device commonly used treatment in patients with VTE—despite its association with potentially new DVT development or existing DVT propagation.

Improving VTE Research: Where to Start?

July 22, 2020

Video

An expert explains why little progress has been made in disease prevalence and burden in the US.

Treating Combined High Lipoprotein, Inflammation Reduces MACE Risks

July 20, 2020

Article

A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.

x